- Home
- CIF vs SCNX Comparison
CIF vs SCNX Comparison
Compare CIF & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIF | SCNX |
|---|---|---|
| Founded | 1988 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 24.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CIF | SCNX |
|---|---|---|
| Price | $1.72 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.9K | ★ 1.7M |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 10.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $653,391.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 207.88 |
| 52 Week Low | $1.47 | $0.46 |
| 52 Week High | $1.77 | $8.19 |
Technical Indicators
Market Signals| Indicator | CIF | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 38.55 |
| Support Level | $1.68 | $0.50 |
| Resistance Level | $1.76 | $0.75 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 21.43 | 0.52 |
Price Performance
Historical ComparisonAbout CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.